Field experiments MEK inhibitor were conducted over two consecutive seasons at the Breeza Research Station (New South Wales Department of Primary Industries) located on the Liverpool Plains of northern New South Wales (NSW), Australia (150°25′31″ E and 31°10′54″ S). Plots were sown with varieties Baxter, Ellison and Hybrid Mercury (HM) in 2006. In 2007, varieties Ellison and H45 were grown.

Among these varieties, HM and H45 were considered highly susceptible, Baxter moderately resistant and Ellison resistant to pathotype (134 E16 A +), which was the dominant pathotype in eastern Australia during the years in which the experiments were conducted. In both years wheat was grown in experimental plots of 10 m length and 1.8 m width. Spacing between rows was 40 cm and sowing rate was adjusted based on grain weight and germination of the various wheat varieties so as to attain a target plant population of 100 plants m− 2. In both years, N rates of 0, 50, 100, 200 or 300 kg ha− 1 were established by application of granular urea prior to sowing. The trial areas in Ruxolitinib clinical trial both years deliberately followed a long fallow from a previous sorghum crop to ensure low starting soil

N reserves. Soil N levels were measured to 1.2 m prior to sowing in each year with a total of 64 kg ha− 1 nitrate N available in 2006 and 42 kg ha− 1 nitrate N in 2007. All plots were inoculated with Pst spores prior to

a rain event during tillering in each season to supplement natural inoculation with wind-blown spores from neighbouring fields. Low-disease plots were then established in each trial by treatment of seed with fluquinconazole (Jockey-Bayer Crop Science at 450 mL 100 kg− 1 seed) prior to sowing and foliar applications of tebuconazole (Folicur-Bayer Crop Science at 290 mL ha− 1) at the start of booting (GS32) and full flag leaf emergence (GS39). In 2006 the fungicide treatment was applied to N-acetylglucosamine-1-phosphate transferase all varieties, but in 2007 it was applied only to the susceptible variety H45 because Ellison was highly resistant to the dominant pathotype at the time of the trial. The experimental design in 2006 was a split-plot design with fungicide treatment as the main plot factor, and variety and nitrogen as the subplot factors. In 2007 a randomised complete block design was used. There were four replicates in both years. Disease severity (percentage of leaf area covered in pustules) was visually estimated using a standard scale from the Australian Cereal Rust Laboratory, University of Sydney [7]. This scale measures the severity of stripe rust using scores ranging from one (no symptoms) to nine (abundant sporulation across the whole leaf area with no evidence of individual stripes).